国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Jannaschia sp. ATP synthase epsilon chain (atpC) CSB-YP645810JAAA
CSB-EP645810JAAA
CSB-BP645810JAAA
CSB-MP645810JAAA
CSB-EP645810JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Histidinol-phosphate aminotransferase (hisC) CSB-YP645811JAAA
CSB-EP645811JAAA
CSB-BP645811JAAA
CSB-MP645811JAAA
CSB-EP645811JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 30S ribosomal protein S4 (rpsD) CSB-YP645812JAAA
CSB-EP645812JAAA
CSB-BP645812JAAA
CSB-MP645812JAAA
CSB-EP645812JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. ATP synthase subunit c (atpE), partial CSB-YP645813JAAA1
CSB-EP645813JAAA1
CSB-BP645813JAAA1
CSB-MP645813JAAA1
CSB-EP645813JAAA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. tRNA (guanine-N (7)-)-methyltransferase (trmB) CSB-YP645814JAAA
CSB-EP645814JAAA
CSB-BP645814JAAA
CSB-MP645814JAAA
CSB-EP645814JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Protein CrcB homolog (crcB), partial CSB-YP645815JAAA1
CSB-EP645815JAAA1
CSB-BP645815JAAA1
CSB-MP645815JAAA1
CSB-EP645815JAAA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 30S ribosomal protein S5 (rpsE) CSB-YP645816JAAA
CSB-EP645816JAAA
CSB-BP645816JAAA
CSB-MP645816JAAA
CSB-EP645816JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 50S ribosomal protein L29 (rpmC) CSB-YP645817JAAA
CSB-EP645817JAAA
CSB-BP645817JAAA
CSB-MP645817JAAA
CSB-EP645817JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 50S ribosomal protein L4 (rplD) CSB-YP645818JAAA
CSB-EP645818JAAA
CSB-BP645818JAAA
CSB-MP645818JAAA
CSB-EP645818JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP645819JAAA
CSB-EP645819JAAA
CSB-BP645819JAAA
CSB-MP645819JAAA
CSB-EP645819JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP645820JAAA
CSB-EP645820JAAA
CSB-BP645820JAAA
CSB-MP645820JAAA
CSB-EP645820JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. 50S ribosomal protein L20 (rplT) CSB-YP645821JAAA
CSB-EP645821JAAA
CSB-BP645821JAAA
CSB-MP645821JAAA
CSB-EP645821JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Ribonuclease HII (rnhB) CSB-YP645822JAAA
CSB-EP645822JAAA
CSB-BP645822JAAA
CSB-MP645822JAAA
CSB-EP645822JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Zinc import ATP-binding protein ZnuC (znuC) CSB-YP645823JAAA
CSB-EP645823JAAA
CSB-BP645823JAAA
CSB-MP645823JAAA
CSB-EP645823JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Chaperone protein DnaK (dnaK), partial CSB-YP645824JAAA
CSB-EP645824JAAA
CSB-BP645824JAAA
CSB-MP645824JAAA
CSB-EP645824JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Shikimate dehydrogenase (aroE) CSB-YP645825JAAA
CSB-EP645825JAAA
CSB-BP645825JAAA
CSB-MP645825JAAA
CSB-EP645825JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Light-independent protochlorophyllide reductase iron-sulfur ATP-binding protein (bchL) CSB-YP645826JAAA
CSB-EP645826JAAA
CSB-BP645826JAAA
CSB-MP645826JAAA
CSB-EP645826JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Jannaschia sp. Translation initiation factor IF-2 (infB), partial CSB-YP645827JAAA
CSB-EP645827JAAA
CSB-BP645827JAAA
CSB-MP645827JAAA
CSB-EP645827JAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila pseudoobscura pseudoobscura Protein king tubby (king-tubby) CSB-YP645828DME
CSB-EP645828DME
CSB-BP645828DME
CSB-MP645828DME
CSB-EP645828DME-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila pseudoobscura pseudoobscura Pre-mRNA-splicing regulator female-lethal (2)D (fl (2)d), partial CSB-YP645829DME
CSB-EP645829DME
CSB-BP645829DME
CSB-MP645829DME
CSB-EP645829DME-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>